Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients

Brain, Behavior, and Immunity

Volumn 24, Issue 3, 2010, Pages 366-369

  Wirtz, Petra H ^a,b   Redwine, Laura S ^b   Linke, Sarah ^b   Hong, Suzi ^b   Rutledge, Thomas ^b   Greenberg, Barry H ^c   Mills, Paul J ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

CRP; Depression prediction; Heart failure; IL 6; SICAM 1

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; WARFARIN;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DEPRESSION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DRUG USE; FEMALE; HEART FAILURE; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

ACUTE-PHASE PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER; FEMALE; HEART FAILURE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 77951593633     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.02.004     Document Type: Article

References (20)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC.
2. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 2004, 66:411-421.
3. Beck A.T. Depression Inventory 1978, Center for Cognitive Therapy, Philadelphia.
4. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 1993, 11:767-804.
5. Blann A.D., Byrne G.J., Baildam A.D. Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response. Blood Coagul. Fibrinolysis 2002, 13:165-168.
6. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
7. Deswal A., Petersen N.J., Feldman A.M., Young J.B., White B.G., Mann D.L. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 2001, 103:2055-2059.
8. Faul, F., 2007. G-Power Version 3.0.10. Buchner, A., Erdfelder, E., Faul, F., Kiel, Germany.
9. Mari D., Di Berardino F., Cugno M. Chronic heart failure and the immune system. Clin. Rev. Allergy Immunol. 2002, 23:325-340.
10. Mills P.J., Goebel M., Rehman J., Irwin M.R., Maisel A.S. Leukocyte adhesion molecule expression and T cell naive/memory status following isoproterenol infusion. J. Neuroimmunol. 2000, 102:137-144.
11. Moorman A.J., Mozaffarian D., Wilkinson C.W., Lawler R.L., McDonald G.B., Crane B.A., Spertus J.A., Russo J.E., Stempien-Otero A.S., Sullivan M.D., Levy W.C. In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. J. Card. Fail. 2007, 13:738-743.
12. O'Keeffe S.T., Lye M., Donnellan C., Carmichael D.N. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998, 80:377-382.
13. Parissis J.T., Adamopoulos S., Rigas A., Kostakis G., Karatzas D., Venetsanou K., Kremastinos D.T. Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. Am. J. Cardiol. 2004, 94:1326-1328.
14. Parissis J.T., Fountoulaki K., Paraskevaidis I., Kremastinos D. Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches. Expert Opin. Investig. Drugs 2005, 14:567-577.
15. Redwine L.S., Mills P.J., Hong S., Rutledge T., Reis V., Maisel A., Irwin M.R. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom. Med. 2007, 69:23-29.
16. Rehman J., Mills P.J., Carter S.M., Chou J., Thomas J., Maisel A.S. Dynamic exercise leads to an increase in circulating ICAM-1: further evidence for adrenergic modulation of cell adhesion. Brain Behav. Immun. 1997, 11:343-351.
17. Roberts W.L., Moulton L., Law T.C., Farrow G., Cooper-Anderson M., Savory J., Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin. Chem. 2001, 47:418-425.
18. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J. Am. Coll. Cardiol. 2006, 48:1527-1537.
19. van den Biggelaar A.H., Gussekloo J., de Craen A.J., Frolich M., Stek M.L., van der Mast R.C., Westendorp R.G. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp. Gerontol. 2007, 42:693-701.
20. York, K.M., Hassan, M., Sheps, D.S., 2008. Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev.